Generic And Branded Mifepristone Remain On US Market Following Supreme Court Stay
No New Restrictions Will Be Placed On The Drug As Court Cases Play Out
A stay from the Fifth Circuit would have suspended GenBioPro's ANDA, but this has been overruled by a stay from the Supreme Court 
